Villanova, PA, United States of America

Greg H Enders

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.1

ph-index = 1


Location History:

  • Villanova, PA (US) (2014 - 2015)
  • Philadelphia, PA (US) (2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Greg H Enders

Introduction

Greg H Enders is a notable inventor based in Villanova, PA, who has made significant contributions to the field of cancer research. With a total of three patents, his work focuses on innovative systems and methods for diagnosing and treating cancers, particularly prostate and colon cancer. His inventions aim to improve patient outcomes through advanced genetic analysis and treatment strategies.

Latest Patents

One of Greg H Enders' latest patents is titled "Systems and methods for treating patients having a genetic predisposition to develop prostate cancer." This invention provides methods for evaluating peripheral blood cells for the presence of gamma-H2AX foci and gene alterations that correlate with prostate cancer development. The patent highlights the importance of specific genes, such as AKR1C1, BRCA1, and TP53BP1, in understanding and mitigating the risks associated with prostate cancer.

Another significant patent is "Systems and methods for diagnosing a predisposition to develop colon cancer." This invention outlines methods for assessing cell nuclei for gamma-H2AX foci and evaluating nucleic acids for genomic instability. The focus is on identifying alterations in genes like ERCC6 and TERT that may predispose individuals to colon cancer, thereby enabling early diagnosis and intervention.

Career Highlights

Greg H Enders has worked with esteemed organizations such as the Institute for Cancer Research and Fox Chase Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment and diagnosis.

Collaborations

Throughout his career, Greg has collaborated with notable colleagues, including Sanjeevani Arora and Erica A Golemis. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer therapies.

Conclusion

Greg H Enders is a pioneering inventor whose work in cancer research has the potential to transform patient care. His patents reflect a commitment to advancing medical science and improving the lives of those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…